Reported about 2 months ago
In a recent discussion on investment strategies in the healthcare sector, Washington Crossing Advisors' Chad Morganlander identifies Elevance Health as a promising stock due to its favorable government pricing exposure and strong leadership. In contrast, he warns investors to avoid CVS Health, citing its heavy debt from the Aetna acquisition and a diminished competitive advantage as retail operations slow.
Source: YAHOO